STRENGTH IN NUMBERS

Strength in Numbers dedicated to my late mother Kay

Thousands of breast cancer deaths could be prevented by drug that prevent bone thinning

  • 50,000 new cases of breast cancer are diagnosed by doctors each year
  • Scientists find bone thinning drugs could prevent 1,300 deaths a year
  • The 5p pill slashes risk of cancer spreading to bone by 28 per cent
  •  Also, reduces the likelihood of the disease returning by 14 per cent 

Pills costing just 5p a day could save the lives of thousands of breast cancer sufferers, according to research. Drugs used to prevent bone thinning slash the risk of dying from tumours by 20 per cent, researchers found.  They say that if the pills – called bisphosphonates – were routinely given to women with breast cancer they would prevent 1,300 deaths a year and ‘several thousands’ within a decade. But campaigners say there is a danger the drugs will remain ‘sitting on the shelf’ in chemists because NHS red tape prevents doctors from routinely prescribing them for breast cancer.

Bisphosphonates are currently only ‘licensed’ – passed as safe – to be used for osteoporosis and for some women whose cancer has weakened the bone. Campaigners are urging the Government and the NHS to change the guidelines to enable doctors to routinely offer them to all women diagnosed with breast cancer after the menopause.

Click on the link to read more

http://www.dailymail.co.uk/health/article-3172766/Red-tape-deny-breast-cancer-victims-5p-day-pill.html?ITO=1490&ns_mchannel=rss&ns_campaign=1490

0249520F0000044D-0-image-a-28_1437690801116

Filed under: Cancer, , , ,

NHS will not offer ‘innovative’ drug to treat prostate cancer

Cancer charities are disappointed with health officials who have deemed a new and ‘innovative’ drug to treat advanced prostate cancer is not cost-effective for the NHS.

Enzalutamide is currently available on the Cancer Drugs Fund in England, which enables patients to access drugs that would not otherwise have been routinely available from the NHS. But the National Institute for Health and Care Excellence (Nice) has published draft guidance in which it says the drug has not been proven to work well enough for the price the NHS must pay for it.

The drug, also called Xtandi, is licensed to treat people with prostate cancer that has spread to other parts of the body who have not yet had chemotherapy, and in whom treatments to lower the amount of male sex hormones – which normally stop the cancer from growing and spreading – no longer work.

Click on the link to read more

http://www.itv.com/news/2015-06-11/nhs-will-not-offer-innovative-drug-to-treat-prostate-cancer/

stream_img

Filed under: Cancer, , , , ,

Blog views to date

  • 98,552 hits

Enter your email address to subscribe to The Last Six Months and receive notifications of new posts by email.

Join 1,429 other followers

Helpful Pages, Templates etc

Recent Posts

Pages